Home > Financial Ratios > SMS PHARMACEUTICALS

SMS PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
SMS PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for SMS PHARMACEUTICALS
Please provide your vote to see the results

SMS PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Core EBITDA Growth(%) -50.38-3.8346.34-8.99-2.28

What is the latest Core EBITDA Growth ratio of SMS PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of SMS PHARMACEUTICALS is -50.38 based on Mar2023 Consolidated results.
Year Core EBITDA Growth
Mar2023-50.38
Mar2022-3.83
Mar202146.34
Mar2020-8.99
Mar2019-2.28

How is Core EBITDA Growth of SMS PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2023 -50.38
Negative
Mar2022 -3.83
Negative
Mar2021 46.34
Positive
Mar2020 -8.99
Negative
Mar2019 -2.28 -

Other Financial Ratios of SMS PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of SMS PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SMS PHARMACEUTICALS ₹1,754.6 Cr -2% 11.9% 148.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹365,167.0 Cr 2.6% -4.7% 54.7% Stock Analytics
CIPLA ₹113,645.0 Cr 4.4% -4.4% 54.7% Stock Analytics
DIVIS LABORATORIES ₹105,890.0 Cr 5.8% 17.7% 24.8% Stock Analytics
DR REDDYS LABORATORIES ₹104,987.0 Cr 5.7% 2.7% 29.3% Stock Analytics
ZYDUS LIFESCIENCES ₹96,950.6 Cr 0.4% -5.4% 82.7% Stock Analytics


SMS PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SMS PHARMACEUTICALS

-2%

11.9%

148.4%

SENSEX

1.4%

2.5%

24.3%


You may also like the below Video Courses